BackCytoMed Therapeutics Overview

CytoMed Therapeutics Total Current Liabilities

Track CytoMed Therapeutics's total current liabilities ($710K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$709169.00
↑ 59.48% YoYΔ $264497.00 vs prior year quarter

Peer trimmed avg / median

Loading

CytoMed Therapeutics Total Current Liabilities History

Loading

CytoMed Therapeutics vs. peers: Total Current Liabilities Comparison

Loading

CytoMed Therapeutics Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

CytoMed Therapeutics (GDTC) FAQ

As of the most recent data (December 2025), GDTC shows a total current liabilities of $710K. That compares with $440K in the prior-year period — up 59.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, GDTC's total current liabilities is now $710K (was $440K) — a 59.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether CytoMed Therapeutics is outperforming or lagging.

Tracking GDTC's total current liabilities over time shows whether CytoMed Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $710K That compares with $440K in the prior-year period — up 59.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total current liabilities page, Stockcircle has CytoMed Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $710K) with ownership activity and broader fundamentals.